PONTES JOSIAS enters SIGILON THERAPEUTICS, INC. with 600.00 shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 6/21/2021ACC: 0001415889-21-003113
Officer· VP, Head of Finance
Since Jun 2021
600.00
Baseline shares
100% direct
600.00
Direct ownership
1 position
92.55K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned600.00
Total
600.00 direct600.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 600.00 | Direct |
| Total | 600.00 | 600.00 direct |
Derivative Holdings3
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
25K
Shares owned
N/A
Exercise price
39.81
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
888.00
Shares owned
N/A
Exercise price
9.39
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
66.67K
Shares owned
N/A
Exercise price
8.87
Expiration
—
Exercise window
—
Total
Underlying
92.55K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 39.81 | — | — | 25K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 9.39 | — | — | 888.00 | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 8.87 | — | — | 66.67K | N/A |
| Total | 92.55K | 0.00 | ||||